| scholarly article | Q13442814 |
| P50 | author | Reza Dana | Q16206939 |
| Nambi Nallasamy | Q82431875 | ||
| P2093 | author name string | Qiang Zhang | |
| Sunil K Chauhan | |||
| Jaafar El Annan | |||
| Sunali Goyal | |||
| P2860 | cites work | Prevalence of dry eye syndrome among US women | Q28196875 |
| Corneal avascularity is due to soluble VEGF receptor-1 | Q28755125 | ||
| Characterization of effector T cells in dry eye disease | Q34065949 | ||
| Topical omega-3 and omega-6 fatty acids for treatment of dry eye. | Q34749224 | ||
| Role of VEGF-D and VEGFR-3 in developmental lymphangiogenesis, a chemicogenetic study in Xenopus tadpoles. | Q34778250 | ||
| Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing | Q35810121 | ||
| Immune privilege and angiogenic privilege of the cornea | Q36722791 | ||
| Lymphatic endothelial cells, inflammatory lymphangiogenesis, and prospective players | Q36952220 | ||
| Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression | Q37071969 | ||
| Immunological functions of hyaluronan and its receptors in the lymphatics | Q37548667 | ||
| Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in the conjunctiva--a potential link between lymphangiogenesis and leukocyte trafficking on the ocular surface. | Q40667082 | ||
| VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment | Q40725945 | ||
| Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages | Q41887679 | ||
| The crucial role of macrophages in lymphangiogenesis | Q41945366 | ||
| Role of Th17 cells in the immunopathogenesis of dry eye disease | Q42694095 | ||
| Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye. | Q45950875 | ||
| Modulation of integrin alpha4beta1 (VLA-4) in dry eye disease | Q46209348 | ||
| The controlled-environment chamber: a new mouse model of dry eye. | Q46618772 | ||
| Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity | Q47244359 | ||
| LYVE-1-positive macrophages are present in normal murine eyes. | Q50687535 | ||
| The VEGF Family, the Inside Story | Q57382043 | ||
| Inhibition of Hemangiogenesis and LymphangiogenesisafterNormal-Risk Corneal Transplantation by Neutralizing VEGF Promotes Graft Survival | Q57706454 | ||
| Desiccating Stress Induces T Cell-Mediated Sjogren's Syndrome-Like Lacrimal Keratoconjunctivitis | Q61851332 | ||
| The critical role of lymph nodes in corneal alloimmunization and graft rejection | Q73819698 | ||
| Research in dry eye: report of the Research Subcommittee of the International Dry Eye WorkShop (2007) | Q80347923 | ||
| Lymphangiogenesis in development and disease | Q80774020 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| lymphangiogenesis | Q6708231 | ||
| P304 | page(s) | 819-824 | |
| P577 | publication date | 2010-07-01 | |
| P1433 | published in | JAMA Ophthalmology | Q4787301 |
| P1476 | title | Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity? | |
| P478 | volume | 128 |
| Q35525349 | A novel pro-lymphangiogenic function for Th17/IL-17. |
| Q35773063 | Age-related Defects in Ocular and Nasal Mucosal Immune System and the Immunopathology of Dry Eye Disease |
| Q42492752 | Angiopoietin 2 expression in the cornea and its control of corneal neovascularisation |
| Q38369119 | Anti-inflammatory effect of hydroxyproline-GQDGLAGPK in desiccation stress-induced experimental dry eye mouse |
| Q36776787 | Blockade of prolymphangiogenic vascular endothelial growth factor C in dry eye disease |
| Q34211406 | CCR7 is critical for the induction and maintenance of Th17 immunity in dry eye disease |
| Q37067291 | Chronic dry eye disease is principally mediated by effector memory Th17 cells |
| Q47336283 | Comparison of Autologous Serum Versus Preservative Free Artificial Tear in Patients with Dry Eyes Due to Systemic Isotretinoin Therapy. |
| Q36601706 | Comparison of postoperative corneal changes between dry eye and non-dry eye in a murine cataract surgery model |
| Q35864899 | Conjunctival lymphatic response to corneal inflammation in mice |
| Q38260206 | Consensus statement on the immunohistochemical detection of ocular lymphatic vessels |
| Q34881185 | Corneal Lymphatics: Role in Ocular Inflammation as Inducer and Responder of Adaptive Immunity |
| Q50098128 | Corneal Tissue From Dry Eye Donors Leads to Enhanced Graft Rejection. |
| Q37671066 | Corneal lymphatic valve formation in relation to lymphangiogenesis |
| Q34277464 | Doxycycline inhibits inflammation-induced lymphangiogenesis in mouse cornea by multiple mechanisms |
| Q39404635 | Dry Eye Management: Targeting the Ocular Surface Microenvironment. |
| Q34647761 | Dry eye as a mucosal autoimmune disease |
| Q36916372 | Dry eye disease: an immune-mediated ocular surface disorder |
| Q37485819 | Effect of trapping vascular endothelial growth factor-A in a murine model of dry eye with inflammatory neovascularization |
| Q36044544 | Efficacy of topical blockade of interleukin-1 in experimental dry eye disease |
| Q37013881 | Expression of toll-like receptor 4 contributes to corneal inflammation in experimental dry eye disease |
| Q64079159 | Hyaluronan Derived From the Limbus is a Key Regulator of Corneal Lymphangiogenesis |
| Q36393194 | Improvement in the signs and symptoms of dry eye disease with dobesilate eye drops |
| Q35864976 | Lymphatics and lymphangiogenesis in the eye. |
| Q50078702 | MiR-199a/b-5p Inhibits Lymphangiogenesis by Targeting Discoidin Domain Receptor 1 in Corneal Injury. |
| Q35907009 | Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease |
| Q61445581 | Phase-specific functions of macrophages determine injury-mediated corneal hem- and lymphangiogenesis |
| Q50419857 | Potential lymphangiogenesis therapies: Learning from current antiangiogenesis therapies-A review. |
| Q37581630 | Recent developments on dry eye disease treatment compounds |
| Q34510429 | The core mechanism of dry eye disease is inflammation |
| Q28083825 | The pathophysiology, diagnosis, and treatment of dry eye disease |
| Q36989668 | Therapeutic efficacy of topical epigallocatechin gallate in murine dry eye. |
| Q41244028 | Transient Ingrowth of Lymphatic Vessels into the Physiologically Avascular Cornea Regulates Corneal Edema and Transparency |
| Q36808641 | Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions. |
| Q36892952 | b-FGF induces corneal blood and lymphatic vessel growth in a spatially distinct pattern |
Search more.